Trial Profile

Non-Interventional Study to Investigate Efficacy and Safety of Nab-Paclitaxel in Patients With Metastatic Breast Cancer

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 27 Jun 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Paclitaxel (Primary)
Indications Advanced breast cancer
Focus Therapeutic Use
Acronyms Nabucco
Sponsors iOMEDICO AG

Most Recent Events

12 Sep 2017 Final results of the study assessing overall survival and quality of life, presented at the 42nd European Society for Medical Oncology Congress.
02 Jun 2017 Results presented at the 53rd Annual Meeting of the American Society of Clinical Oncology
11 Oct 2016 Results of effectiveness analyses by treatment line presented at the 41st European Society for Medical Oncology Congress

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com